Home » Tet Systems Acquires Patent Rights from AMC

Tet Systems Acquires Patent Rights from AMC

Dec 02, 2009

NEW YORK (GenomeWeb News) – Tet Systems has acquired from The Academic Medical Center (AMC) and the Technology Foundation STW in the Netherlands the rights to use and commercialize gene expression-related Tet technologies covered by eight patent applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

What's Popular?

In Gene Expression Research

  1. Researchers Use ZFNs to Edit Mutation in Mitochondrial DNA In Vivo

  2. Acute Sleep Deprivation Linked to Shift in Blood-Based Gene Expression

  3. SenzaGen Positions New In Vitro Test for Airway Allergies as Alternative to Animal Testing

    Premium

  4. Long Noncoding RNAs Classified Based on Sequence Motifs

  5. Highly Efficient Genome Editing Method Reveals Fitness of Genetic Variants in Yeast

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.